Patient's Needs For Medication Adherence Are Still Unclear

Published Mar 17, 2013
Karachi, Pakistan - Medication non-adherence is a global issue. Physicians are deemed responsible for assessing medication non-adherence, however, other health professionals, such as pharmacists may also be involved. Unfortunately, neither the health professionals nor the patients they are assessing are taking it seriously. In the article, “Disparity Between Health Care Professionals and Low Socioeconomic Patients with Respect to Factors Associated to Medication Non-Adherence in Karachi,” published in Vol. 19 Issue 1 of ISPOR CONNECTIONS, the authors attempted to compare health care professionals’ perceptions of medication non-adherence with the patients’ data, from a remote part of Karachi, Sikandarabad. A gap was noticed between the health professionals understanding of the patients’ need for medication adherence. The perception of the health professionals, with respect to the patients’ needs for non-adherence, is different than the patients’ perspective. The three major differences are: cost as a major factor for primary non-adherence, the perception that providing information about medication adverse effects would result in non-adherence, and the source of drug information. As a result, some of the patients stop the medication early or do not take the medication as per the prescription. Mr. Muhammad Amir, BPharm, Msc, MBA, author of the study states, “Medication non-adherence is like a disease; it needs assessment, treatment and further research.”

ISPOR CONNECTIONS (ISSN 1538-5108), the bimonthly news & technical journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), strives to provide timely communications on methodological and health policy issues of interest to Society members.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information:

Related Stories

Global Experts Introduce Strategic Action Plan to Accelerate Patient Access to Next-Generation DNA Sequencing in Oncology

Sep 27, 2022

Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology,” that details the challenges in improving patient access to next-generation DNA sequencing and proposes a plan of action to improve access.

Alzheimer’s Disease: Modifying Value Frameworks to Evaluate Current and Emerging Interventions

Mar 15, 2021

Value & Outcomes Spotlight announced the publication of a special supplement exploring value assessment of new interventions in Alzheimer’s disease. The supplement, “Valuing Future Alzheimer’s Disease Treatments: The Need for a Holistic Approach,” was sponsored by Biogen and is based on a series of educational webinars produced by Biogen and ISPOR.

Virtual ISPOR Europe 2020 Live Conference Concluded

Nov 23, 2020

ISPOR announced that its Virtual ISPOR Europe 2020 conference, “Improving Health: Establishing Incentives and Sharing Value,” is now available on demand through 31 December 2020. ISPOR Europe is the leading European conference for health economics and outcomes research.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now